Completed NA INTERVENTIONAL 2-arm NCT00427037

Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects

Efficacy of Cholecalciferol (Vitamin D3) Therapy in Correcting Vitamin D Insufficiency and Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease: A Randomized, Placebo Controlled Pilot Study

Sponsor: Atlanta VA Medical Center

Conditions Chronic Kidney Disease Vitamin D Deficiency

Interventions Cholecalciferol Placebo

Updated 7 times since 2017 Last updated: Jul 20, 2015 Started: Dec 31, 2005 Primary completion: Jul 31, 2006 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00427037, this NA trial focuses on Chronic Kidney Disease and Vitamin D Deficiency and remains completed. Sponsored by Atlanta VA Medical Center, it has been updated 7 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Atlanta VA Medical Center

Data source: Atlanta VA Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Atlanta, United States